Edition:
United Kingdom

Summit Therapeutics PLC (SMMT.OQ)

SMMT.OQ on NASDAQ Stock Exchange Global Market

12.24USD
7:32pm GMT
Change (% chg)

$-0.44 (-3.47%)
Prev Close
$12.68
Open
$12.80
Day's High
$12.80
Day's Low
$12.12
Volume
10,401
Avg. Vol
8,156
52-wk High
$16.59
52-wk Low
$8.80

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Apr-18 2 5.98 8.76 3.21 1.00
Quarter Ending Jul-18 2 9.05 13.77 4.32 1.00
Year Ending Jan-18 2 38.78 42.24 35.32 8.97
Year Ending Jan-19 5 16.89 41.38 5.00 11.92
Earnings (per share)
Quarter Ending Apr-18 3 -0.14 -0.07 -0.22 --
Quarter Ending Jul-18 3 -0.15 -0.07 -0.23 --
Year Ending Jan-18 3 -0.32 -0.05 -0.78 -1.11
Year Ending Jan-19 3 -0.71 -0.28 -1.27 -0.38
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.57 32.89
P/E High - Last 5 Yrs. -- 278.73 45.60
P/E Low - Last 5 Yrs. -- 91.13 24.32
Beta -- 0.86 0.89
Price to Sales (TTM) -- 96.46 5.41
Price to Book (MRQ) -- 13.15 5.38
Price to Tangible Book (MRQ) -- 13.30 6.76
Price to Cash Flow (TTM) -- 72.66 23.42
% Owned Institutions -- 9.23 1.81

Dividends

  Company industry sector
Dividend Yield -- 0.37 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.51
Dividend 5 Year Growth Rate -- 1.77 5.22
Payout Ratio(TTM) -- 17.09 43.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.27 9.01
Sales (TTM) vs TTM 1 Yr. Ago -- 71.40 5.40
Sales - 5 Yr. Growth Rate -- 32.88 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 28.23 19.39
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 42.28 10.80
Capital Spending - 5 Yr. Growth Rate -- 40.23 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.75 2.18
Current Ratio (MRQ) -- 5.29 2.97
LT Debt to Equity (MRQ) -- 22.29 11.90
Total Debt to Equity (MRQ) -- 23.87 16.16
Interest Coverage (TTM) -- -104.72 33.26

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.78 54.87
Gross Margin - 5 Yr. Avg. -- 52.54 52.46
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -245.78 15.31
Operating Margin (TTM) -- -530.39 7.77
Operating Margin - 5 Yr. Avg. -- -263.25 10.80
Pre-Tax Margin (TTM) -- -505.16 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -263.07 11.21
Net Profit Margin (TTM) -- -506.76 4.88
Net Profit Margin - 5 Yr. Avg. -- -266.42 7.51
Effective Tax Rate (TTM) -- 23.32 23.08
Effective Tax Rate - 5 Yr. Avg. -- 18.85 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 24,014,979 859,857,503
Net Income/Employee (TTM) -- 3,190,719 101,151,730
Receivable Turnover (TTM) -- 20.63 5.76
Inventory Turnover (TTM) -- 2.12 3.33
Asset Turnover (TTM) -- 0.38 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 0.21 10.99
Return on Assets - 5 Yr. Avg. -- 0.98 12.42
Return on Investment (TTM) -- 3.42 14.44
Return on Investment - 5 Yr. Avg. -- 4.35 16.26
Return on Equity (TTM) -- 5.38 16.10
Return on Equity - 5 Yr. Avg. -- 8.97 17.54

Performance for Summit Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 28.76%
# of Holders: 23
Total Shares Held: 4,063,297
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.